Lexington Hill Partners, LLC

Position in ABBV — AbbVie Inc.

CIK 2111980 DALLAS, TX

Position in ABBV

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$324,112

+$66,387 QoQ

Shares Held

1,288

+8.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.66%

of 13F equity value

Holder Rank

#3,557

of 4,153 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Lexington Hill Partners, LLC holds $1,858,828 across 5 Drug Manufacturers - General names. ABBV ranks #2 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	550	$659,686
2	ABBV	AbbVie Inc. This page	1,288	$324,112
3	JNJ	Johnson & Johnson	1,237	$314,160
4	MRK	Merck & Co., Inc.	2,328	$299,148
5	NVS	Novartis AG	1,670	$261,722

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$324,112	1,288	+8.7%	Shares	Sole	2026-07-08
2026-03-31	$257,725	1,185	+16.7%	Shares	Sole	2026-04-16
2025-12-31	$231,917	1,015	—	Shares	Sole	2026-02-19
No filing history on record for this holder in this stock.